Ethinylestradiol/drospirenone

Ethinylestradiol/drospirenone
Ethinylestradiol
Drospirenone
Combination of
EthinylestradiolEstrogen
DrospirenoneProgestogen; Progestin; Antimineralocorticoid; Antiandrogen
Names
Trade namesWith 30 μg ethinylestradiol: Yasmin, others
With 20 μg ethinylestradiol: Yaz, Yasminelle, others
Other namesEE/DRSP
Clinical data
Drug classEstrogen; Progestin; Progestogen; Antimineralocorticoid; Antiandrogen
Pregnancy
category
  • AU: B3[1]
  • US: N (Not classified yet)[1]
    Routes of
    use    		By mouth
    External links
    AHFS/Drugs.comProfessional Drug Facts
    US NLMEthinylestradiol/drospirenone
    MedlinePlusa601050
    Legal
    License data
    Legal status
    Identifiers
    CAS Number
    • 164017-31-6
    KEGG
    ATC code

    Ethinylestradiol/drospirenone (EE/DRSP), sold under the brand name Yasmin among others, is a combination of ethinylestradiol (EE), an estrogen, and drospirenone (DRSP), a progestin, antimineralocorticoid, and antiandrogen, which is used as a birth control pill to prevent pregnancy in women.[2][3][4][5] It is also indicated for the treatment of moderate acne, premenstrual syndrome (PMS), premenstrual dysphoric disorder (PMDD), and dysmenorrhea (painful menstruation) in women.[3] The medication is taken by mouth and contains 30 μg EE and 3 mg DRSP per tablet (brand names Yasmin, others) or 20 μg EE and 3 mg DRSP per tablet (brand names Yaz, Yasminelle, Nikki, others).[4][5] A formulation with levomefolic acid (vitamin B9) has also been marketed (brand names Beyaz, Safyral, others), with similar indications.[6][7] EE/DRSP is marketed widely throughout the world.[8]In 2017, it was the 98th most commonly prescribed medication in the United States, with more than eight million prescriptions.[9][10]

    Society and culture

    Cost

    In 2017, it was the 98th most commonly prescribed medication in the United States, with more than eight million prescriptions.[9][10]

    • Ethinylestradiol/drospirenone costs (US)
      Ethinylestradiol/drospirenone costs (US)
    • Ethinylestradiol/drospirenone prescriptions (US)
      Ethinylestradiol/drospirenone prescriptions (US)

    See also

    References

    1. 1 2 "Drospirenone / estradiol (Angeliq) Use During Pregnancy". Drugs.com. 6 September 2018. Archived from the original on 18 March 2020. Retrieved 18 March 2020.
    2. ↑ "Archive copy". Archived from the original on 2021-08-28. Retrieved 2021-03-02.{{cite web}}: CS1 maint: archived copy as title (link)
    3. 1 2 "Archive copy". Archived from the original on 2019-12-23. Retrieved 2021-03-02.{{cite web}}: CS1 maint: archived copy as title (link)
    4. 1 2 "Archive copy" (PDF). Archived (PDF) from the original on 2021-04-02. Retrieved 2021-03-02.{{cite web}}: CS1 maint: archived copy as title (link)
    5. 1 2 "Yaz" (PDF). Archived from the original (PDF) on October 31, 2017. Retrieved October 31, 2017.
    6. ↑ "Archive copy". Archived from the original on 2019-12-23. Retrieved 2021-03-02.{{cite web}}: CS1 maint: archived copy as title (link)
    7. ↑ "Archive copy" (PDF). Archived (PDF) from the original on 2021-03-30. Retrieved 2021-03-02.{{cite web}}: CS1 maint: archived copy as title (link)
    8. ↑ "Archive copy". Archived from the original on 2020-11-29. Retrieved 2021-03-02.{{cite web}}: CS1 maint: archived copy as title (link)
    9. 1 2 "The Top 300 of 2020". ClinCalc. Archived from the original on 12 February 2021. Retrieved 11 April 2020.
    10. 1 2 "Drospirenone; Ethinyl Estradiol - Drug Usage Statistics". ClinCalc. Archived from the original on 8 July 2020. Retrieved 11 April 2020.


    This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.